Transcutaneous in vivo activation of photosensitive agents in blood

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 5484803
SERIAL NO

08384440

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A method destroys or impairs target cells that have selectively accumulated a photosensitizing agent. The target cells are in the bloodstream of an intact animal, which bloodstream and animal further contain non-target cells. Radiation is applied transcutaneously to at least a portion of the intact animal at an intensity effective to impair or destroy selectively the target cells and to leave non-target cells relatively unimpaired. Target cells include leukemia cells, virus-containing cells, parasite-containing cells, and microorganisms such as bacteria, parasites and free viruses.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • VALEANT PHARMACEUTICALS INTERNATIONAL, INC.

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Richter, Anna M Vancouver, CA 27 483

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation